REDWOOD CITY, Calif., Nov. 20, 2013 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a clinical-stage biopharmaceutical company, today announced the closing of its initial public offering of 7,877,500 shares of its common stock at an initial public offering price of $11.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,027,500 additional shares of common stock. Relypsa’s common stock is listed on The NASDAQ Global Select Market under the trading symbol “RLYP.” All of the shares in the offering were offered by Relypsa. Relypsa estimates net proceeds from the offering to be approximately $77.9 million, after deducting underwriting discounts and commissions and estimated offering expenses.
Help employers find you! Check out all the jobs and post your resume.
